Boris Gorovits

Senior Director and Head of the Non-Clinical and Clinical Bioanalysis Group BioMedicine Design
Boris Gorovits
Boris Gorovits is a Senior Director of the Bioanalytical lab at Pfizer. Boris earned Ph.D. in Enzymology from the Moscow State University and later completed postdoctoral research studies in Protein biophysics at the Medical Center, U of Texas at San Antonio, TX. In 2000 Boris joined Wyeth Research (later Pfizer Inc) to work as a bioanalytical group lead with a growing scope of responsibilities. Currently he leads the Bioanalytical group within Biomedicine Design department which is responsible for many aspects of the Regulated and Non-Regulated Bioanalytical support for the pan-Pfizer Biotherapeutic portfolio. Boris co-chairs Pfizer internal Immunogenicity Expert Working Group which is responsible for review of the biotherapeutic immunogenicity risk assessment and mitigation strategies. Recently Boris has been actively involved in industry discussions focusing on PK and immunogenicity assessment bioanalytical support of various modalities, including mAbs, bi-specific antibodies, antibody drug conjugates, gene therapy and CAR-T


No data was found